The practical nurse (PN) applies a preparation with keratolytic properties to both legs of a client with psoriasis. Which finding indicates that the desired effect has been achieved?
Scaly areas of the skin appear softer with less peeling
No purulent drainage present from lesions on the legs
Affected areas are free of localized redness and swelling
Full range of motion without pain of lower extremity joints
The Correct Answer is A
Choice A reason: Keratolytic agents, like salicylic acid, break down keratin in psoriatic plaques, softening scaly skin and reducing peeling. This promotes shedding of thickened, dead skin cells, improving skin texture. Softer, less scaly skin directly indicates the medication’s effect on hyperkeratotic lesions, confirming therapeutic success.
Choice B reason: Absence of purulent drainage indicates no infection but is not the primary goal of keratolytics. These agents target scale reduction, not infection. Psoriasis lesions are typically not purulent, so this finding is unrelated to the medication’s intended effect on skin texture.
Choice C reason: Reduced redness and swelling suggest decreased inflammation, which is not the primary action of keratolytics. Anti-inflammatory agents, like corticosteroids, target these symptoms, while keratolytics focus on scale removal. This finding is irrelevant to the medication’s specific role in psoriasis management.
Choice D reason: Full range of motion without pain relates to joint function, possibly in psoriatic arthritis, but is unrelated to keratolytics, which treat skin lesions. Keratolytics do not affect joint inflammation or mobility, making this choice incorrect for assessing the medication’s skin-specific effects.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Cephalexin, a cephalosporin, has a 5–10% cross-reactivity risk with penicillin allergies due to similar beta-lactam structures. An anaphylactic history increases the risk of severe reactions. Contacting the provider ensures safety, potentially leading to an alternative antibiotic to prevent life-threatening allergic responses.
Choice B reason: Monitoring for rash or hives is reactive and insufficient for a client with a penicillin anaphylaxis history. Cephalexin’s cross-reactivity risk requires proactive avoidance, not just observation, as anaphylaxis can occur rapidly, making this choice inadequate compared to provider consultation.
Choice C reason: Giving cephalexin with an antihistamine does not prevent anaphylaxis, which can be rapid and severe in penicillin-allergic clients. Antihistamines mitigate mild allergies but are ineffective against severe reactions. This choice is unsafe without confirming the drug’s appropriateness first.
Choice D reason: Administering cephalexin as prescribed ignores the significant risk of cross-reactivity with penicillin, given the client’s anaphylactic history. This could trigger a life-threatening reaction, as cephalosporins share structural similarities with penicillins, making immediate administration without verification dangerous.
Correct Answer is D
Explanation
Choice A reason: Diphenhydramine does not facilitate rapid transfusion. It is an antihistamine used to prevent allergic reactions during transfusions, not to alter infusion speed. Rapid infusion depends on clinical protocols and patient tolerance, not antihistamine effects, making this choice incorrect.
Choice B reason: Diphenhydramine does not inhibit antigen-antibody reactions, which occur in transfusion mismatches. It mitigates histamine-mediated allergic symptoms, like itching or hives, but does not prevent immunological reactions. This choice is incorrect, as it misrepresents the drug’s role in symptom management.
Choice C reason: While diphenhydramine may cause sedation, its primary purpose before transfusion is to prevent allergic reactions, not to promote relaxation. Relaxation is a secondary effect, not the clinical rationale for its use, making this choice less accurate than allergy prevention.
Choice D reason: Diphenhydramine, an antihistamine, minimizes allergic reaction symptoms, such as itching or hives, during blood transfusions by blocking histamine receptors. This premedication reduces the risk of mild transfusion-related allergic responses, ensuring patient comfort and safety, making it the correct explanation.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.